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Abstract Research on Saudi Arabian cancer patients is a pri-
ority at King Abdulaziz Medical City (KAMC), Riyadh,
Saudi Arabia. Because there is limited research on the quality
of life (QoL) of Saudi Arabian cancer patients, the aim of this
study was to identify the predictors of the QoL in a sample of
Saudis with cancer. In August 2016, a cross-sectional study
was conducted on 438 patients with a variety of cancer types
(145 breast, 109 colorectal, 38 leukemia, 45 lymphoma, and
99 other types) who attended the Oncology Outpatient Clinics
at KAMC. Sociodemographics, clinical symptoms, and can-
cer treatments were collected for each patient.We used the SF-
36 instrument to assess QoL. Of the cancer patients studied,
28.4% had a family history of cancer, and, according to sub-
group analyses, the elderly, those lacking formal education,
the unemployed, those diagnosed with Stage III/IV, and those
with metastasis had significantly worse physical functions than
the other cancer patients. According to multiple linear regres-
sion analyses, cancer patients who exercised regularly tended
to have better physical function, emotional role function, vital-
ity, social function, and general health (increase in SF-36 scores
of 8.82, 9.75, 5.54, 6.66, and 4.97, respectively). Patients with
first-year-after-cancer diagnosis tended to have poor emotional
wellbeing, social function, and general health (decrease in
SF-36 scores of 5.20, 7.34, and 6.12, respectively). Newly
diagnosed cancer patients and patients who did not exercise
tended to experience significantly poor QoL in several do-
mains; thus, the effectiveness of exercise must be assessed in
Saudi cancer patients as an intervention to improve QoL.
Keywords SF-36 .QoL .Regular exercise .First-year-cancer
diagnosis . Saudi Arabia
Introduction
According to the Saudi Ministry of Health Cancer Registry in
Riyadh, more than 15,653 people in Saudi Arabia (77.6%
were Saudis) were diagnosed with cancer in 2013. The crude
incidence rate was 57.5 per 100,000 population per year. The
Saudi Government’s vision for 2030 is to significantly miti-
gate the challenges faced by the health sector in preventing
cancers through analyzing independent risk factors and
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improving health and control cancer outcomes through
treating the symptoms of cancers.
Cancer not only affects patients physically, but it may also
impact the quality of life (QoL) of cancer survivors negatively
[1, 2]. Recently, much attention has been paid to the negative
impact of cancer and its treatment on the QoL in cancer pa-
tients. Several reports have indicated that greater QoL impair-
ment in patients with cancer may be attributable to treatment
side effects, cancer symptoms, and psychological distress
[2–4].
There is evidence that older age has negative effects on the
QoL in cancer patients [5, 6], while gender has an influence on
the degree of QoL impairment [7]. Lack of education has a
negative effect on cancer patients [7], and low income has also
been negatively associated with QoL in cancer patients
[8–11]. Other factors contributing to QoL impairment may
include clinical presentations of cancer patients such as the
stage, type, and site of the cancer [7, 12]. It has been docu-
mented internationally that measuring the quality of life in
cancer patients is an important aspect of cancer management
and treatment, and could serve as an effective tool for clinical
trials [1, 13–15].
To date, research on QoL in cancer patients in Saudi Arabia
has been insufficient. Only three studies in Saudi Arabia have
addressed the quality of life in cancer patients. Colorectal
cancer [16] and breast cancer [17, 18] patients were reported
to have a low QoL. According to the authors, there are numer-
ous factors associated with a major reduction in all domains of
QoL, including educational level, employment status, patho-
logical staging, and tumor location [16–18]. There are numer-
ous self-report questionnaires used to measure QoL, including
the European Organization for Research and Treatment of
Cancer (EORTC) quality of life [19] which is used by
Almutairi et al. The Short-Form Health Survey SF-36 (the
RAND 36-item) questionnaire [20] is a self-report question-
naire commonly used to assess QoL, and it has been used
consistently in Saudi patients with sickle cell disease [21,
22]. However, there is a paucity of data using SF-36 measure
in Saudi cancer patients.
The impact of sociodemographics, cancer characteristics,
and treatment are important to consider when assessing QoL
in the cancer population. It allows clinicians to describe and
assess the health status of cancer patients, provide interven-
tions, and measure their effectiveness. This study is of interest
to oncologists who provide routine care to cancer patients in
Saudi Arabia. Research on Saudi Arabian cancer patients is a
priority at King Abdulaziz Medical City (KAMC), Riyadh,
Saudi Arabia. In this study, we used data from a study con-
ducted at King Abdulaziz Medical City in Riyadh (KAMC-R)
to determine the impact of sociodemographics, clinical symp-
toms, and cancer treatments on QoL measures in Saudi cancer
patients. We hypothesized that being elderly, newly diagnosed
patients, and the cancer prognosis would have a negative
impact on QoL in Saudi cancer patients. We also hypothesized
that exercise may impact QoL positively in cancer patients.
Materials and Methods
A survey study was conducted in the outpatient oncology
clinics, KAMC, Ministry of National Guard Health Affairs.
The study obtained scientific and ethical approval from the
IRB office at King Abdullah International Medical Research
Center (KAIMRC), Riyadh (# RSS16/004). The study includ-
ed a consecutive sample of cancer patients with different types
of cancer who were attending outpatient oncology clinics for
follow-up with oncology specialists during the study period
(August 14–31/2016). The subjects of the study administered
a one-time survey with a consent form explaining the aims of
the study and asking whether they wanted to complete the
survey. Assent was obtained from parents of all cancer pa-
tients with ages between 14 and 17 years. We obtained written
consent from those patients age 18 years and above.
A total of 540 subjects who consented were administered
the survey, and 436 surveys were completed and returned (145
breast, 45 lymphoma, 109 colorectal, 38 leukemia, and 99
other types of cancer) with a response rate of 80.7%.
Sociodemographics data were collected for each patient such
as age, gender, height, weight, university degree, marital sta-
tus, regular exercise, family support, and employment status.
We collected clinical data on patients and their cancer charac-
teristics such as type of cancer, family history of cancer, can-
cer stage (I, II, III, or IV), multiple tumors, newly diagnosed
cancer patients or first-year-after-cancer diagnosis, whether
patient received chemotherapy, whether patient had surgery
to remove tumors, whether patient received immunotherapy,
whether patient received radiation therapy antibiotics, side
effects of treatment, metastasis, sleep deprivation, fever, and
chronic disease other than cancer. The following section de-
scribes the quality of life questionnaire used to assess patients’
health status.
Quality of Life Instrument
Quality of life was assessed by the Medical Outcomes Study
36-item short-form (SF-36) questionnaire [20], an instrument
with an Arabic version [23] and established reliability that
provides subjective evaluation of quality of life. It has been
used in general and disease-specific populations. The SF-36 is
a self-rated tool comprising 36 items grouped into eight do-
mains: physical function, physical role health, emotional role
functions, vitality, emotional wellbeing, social function, bodi-
ly pain, and general health. Each of these domains ranges from
0 (poor health) to 100 (best health). The SF-36 questionnaire
was found to be reliable in this population with Cronbach’s
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alpha values ranging between 0.60 Bsocial function^ and 0.91
Bphysical function.^
Data Analysis
The data analysis was conducted using IBM SPSS Statistics 23
(SPSS, Chicago, IL).Patients’ characteristics: sample statistics
such as means and standard deviation were used to summarize
numerical data. Counts and percentages were used to summa-
rize categorical data (Table 1). Bivariate analyses: In order to
account for 24 multiple comparisons, the Bonferroni correction
of α/n = 0.05/24 = 0.0021 was used to compare QoL differ-
ences between sociodemographics and clinical characteristics
(Tables 1 and 2, Fig. 1).Multivariate analyses: Multiple linear
regression models were used to examine the relationship be-
tween the sociodemographics, clinical symptoms, and cancer
treatments and each QoL domain, and to identify predictors of
the SF-36 subscales. Regression coefficients were used to in-
terpret the linear regression findings. In all multivariate analy-
ses, the significance level (α) was set at 0.05.
Table 1 Differences in quality of life by sociodemographics and clinical characteristics (N = 436)
Overall Physical functioning Role limitations due
to physical health
Role limitations due to
emotional problems
Vitality
Characteristics n % Mean SD P Mean SD P Mean SD P Mean SD P
Gender Male 157 36.0 46.8 30.8 0.429 24.7 36.6 0.620 33.3 41.9 0.507 44.0 21.6 0.924
Female 279 64.0 49.1 28.7 26.5 37.6 30.6 41.2 43.8 22.3
Elderly No 270 61.9 55.1 27.6 0.001* 25.8 37.3 0.985 32.1 41.0 0.737 46.1 22.0 0.009
Yes 166 38.1 37.2 29.0 25.9 37.1 30.7 42.2 40.4 21.7
University No 312 71.6 44.1 28.8 0.001* 25.9 37.0 0.985 29.9 40.6 0.185 42.2 22.1 0.010
Yes 124 28.4 58.9 28.4 25.8 37.8 35.8 43.4 48.2 21.2
Employed No 321 73.6 45.6 28.3 0.001* 26.5 37.0 0.562 31.5 41.5 0.926 43.2 21.8 0.246
Yes 115 26.4 56.0 31.2 24.1 37.7 31.9 41.5 46.0 22.4
Married No 99 22.7 47.2 30.1 0.678 30.3 38.8 0.177 32.0 40.1 0.911 45.2 23.6 0.524
Yes 337 77.3 48.6 29.3 24.6 36.6 31.5 41.9 43.5 21.5
Obese No 273 71.7 50.1 29.2 0.217 28.0 38.9 0.216 32.8 42.3 0.460 44.4 21.6 0.876
Yes 108 28.3 45.9 31.3 22.9 35.0 29.3 40.9 44.0 23.7
Family history of cancer No 312 71.6 47.5 29.7 0.339 27.6 37.9 0.112 33.3 42.3 0.147 44.9 22.4 0.129
Yes 124 28.4 50.4 28.6 21.4 35.0 27.2 39.0 41.4 20.7
1st year after cancer diagnosis No 196 45.1 46.9 28.1 0.405 21.8 33.7 0.045 32.0 41.5 0.800 42.5 23.3 0.243
Yes 239 54.9 49.2 30.4 28.9 39.4 31.0 41.3 45.0 20.8
Cancer Types Breast 145 33.3 54.4 28.8 0.002* 29.3 38.3 0.292 33.6 42.2 0.137 43.9 20.8 0.242
Colorectal 109 25.0 42.7 26.6 23.4 35.1 32.1 41.6 41.2 22.4
Leukemia 38 8.7 52.9 29.5 23.7 37.2 23.7 38.7 42.1 23.4
Lymphoma 45 10.3 52.8 29.7 32.8 39.8 43.0 42.4 50.0 24.8
Others 99 22.7 41.7 31.2 21.2 36.3 25.9 40.0 44.8 21.2
Stage III/IV I/II 216 58.7 53.1 29.4 0.001* 29.2 38.3 0.006 36.0 43.2 0.001* 47.4 20.3 0.001*
III/IV 152 41.3 42.0 29.1 18.9 32.9 22.1 36.2 38.6 22.5
Multiple tumors No 291 68.5 49.9 29.6 0.034 28.7 38.5 0.003 35.9 42.8 0.001* 46.5 21.7 0.001*
Yes 134 31.5 43.4 28.9 18.1 31.8 22.6 36.9 37.5 21.4
Cancer surgery No 199 45.6 48.1 30.5 0.890 25.0 37.3 0.659 30.5 41.0 0.615 43.6 21.3 0.800
Yes 237 54.4 48.5 28.6 26.6 37.2 32.5 41.8 44.2 22.6
Chemotherapy No 101 23.2 48.2 29.8 0.958 33.7 41.3 0.027 38.3 45.1 0.082 46.6 22.5 0.164
Yes 335 76.8 48.3 29.4 23.5 35.6 29.6 40.1 43.1 21.8
Radiation therapy No 238 54.7 50.3 29.8 0.142 29.0 39.3 0.055 33.3 41.8 0.352 46.4 22.6 0.009
Yes 197 45.3 46.1 28.7 22.2 34.2 29.6 41.1 40.9 20.9
Immunotherapy No 206 47.5 51.3 30.7 0.054 28.5 40.3 0.149 37.1 44.3 0.010 47.0 21.2 0.007
Yes 228 52.5 45.9 27.9 23.4 34.0 26.8 38.2 41.3 22.3
Antibodies No 319 75.2 49.9 29.1 0.115 26.8 38.3 0.477 34.6 43.0 0.013 45.2 22.4 0.123
Yes 105 24.8 44.6 31.1 23.8 34.4 23.8 36.3 41.3 20.8
Metastasis No 303 69.5 51.2 29.0 0.002* 28.5 38.5 0.016 35.1 42.9 0.005 46.9 21.7 0.001*
Yes 133 30.5 41.8 29.5 19.7 33.4 23.6 36.9 37.2 21.3
Fever No 263 60.3 50.4 30.7 0.058 30.1 39.5 0.002* 38.1 43.9 0.001* 46.8 22.1 0.001*
Yes 173 39.7 45.1 27.1 19.4 32.4 21.6 35.2 39.6 21.1
Family support No 37 8.5 49.9 33.0 0.736 26.4 35.3 0.933 42.3 45.6 0.137 43.4 25.7 0.878
Yes 399 91.5 48.2 29.1 25.8 37.4 30.6 40.9 44.0 21.7
Chronic disease other than
cancer
No 271 62.2 52.0 29.1 0.001* 25.9 38.4 0.964 29.4 40.7 0.160 44.7 21.7 0.358
Yes 165 37.8 42.2 29.0 25.8 35.3 35.2 42.5 42.7 22.5
Regular exercise No 293 67.2 44.4 29.6 0.001* 23.2 36.1 0.038 28.0 41.0 0.009 41.1 21.6 0.001*
Yes 143 32.8 56.2 27.4 31.3 39.0 38.9 41.5 49.7 21.7
*The variable is significant using Bonferroni correction cut-off at α/n = 0.05/24 = 0.0021, where n is the number of tests, P=P-value.
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Table 2 Differences in quality of life by sociodemographics and clinical characteristics (N = 436)
Emotional wellbeing Social functioning Pain General health
Characteristics Mean SD P Mean SD P Mean SD P Mean SD P
Gender Male 63.7 19.7 0.479 55.7 26.8 0.470 56.0 27.0 0.020 51.7 16.7 0.528
Female 62.3 20.4 57.7 27.7 49.7 26.8 50.5 18.3
Elderly No 62.1 20.9 0.374 58.9 27.2 0.065 51.4 27.7 0.557 52.2 18.0 0.054
Yes 63.9 18.9 53.9 27.4 52.9 25.9 48.9 17.1
University No 62.2 19.9 0.344 56.8 27.8 0.786 50.2 27.3 0.030 49.6 17.9 0.009
Yes 64.3 20.7 57.6 26.2 56.4 26.0 54.4 17.0
Employed No 62.8 19.6 0.978 57.7 26.6 0.389 51.5 26.1 0.584 49.9 17.5 0.054
Yes 62.9 21.7 55.1 29.3 53.2 29.6 53.7 18.2
Married No 62.5 19.9 0.848 60.0 26.7 0.218 53.9 25.8 0.421 52.3 17.4 0.379
Yes 62.9 20.3 56.1 27.5 51.4 27.4 50.5 17.9
Obese No 63.0 19.7 0.729 56.2 27.7 0.493 53.4 27.5 0.150 51.0 17.6 0.633
Yes 62.2 20.1 58.3 27.2 49.0 25.7 50.0 17.9
Family history of cancer No 64.4 19.9 0.011 58.7 28.0 0.028 54.3 28.0 0.002* 51.7 17.5 0.149
Yes 58.9 20.5 52.6 25.1 46.2 23.5 49.0 18.4
1st year after cancer diagnosis No 63.4 20.9 0.542 58.2 28.0 0.358 51.9 27.5 0.954 51.8 17.4 0.331
Yes 62.2 19.6 55.8 26.7 51.8 26.5 50.1 18.0
Cancer types Breast 61.4 20.0 0.161 58.4 28.2 0.278 49.0 26.6 0.073 50.7 19.2 0.564
Colorectal 65.7 20.3 54.6 24.0 52.7 26.2 50.0 14.8
Leukemia 60.9 21.8 56.6 27.4 56.8 25.0 49.1 20.6
Lymphoma 67.1 21.6 64.2 28.7 60.8 29.3 54.9 16.1
Others 60.5 18.5 54.5 28.8 49.6 27.5 51.2 18.2
Stage III/IV I/II 64.0 18.7 0.011 61.8 23.9 0.001* 55.4 25.5 0.001* 53.3 16.0 0.001*
III/IV 58.4 21.7 50.7 29.4 43.8 26.7 46.5 18.2
Multiple tumors No 64.5 19.7 0.003 59.4 26.3 0.004 55.6 26.5 0.001* 52.7 17.1 0.001*
Yes 58.3 20.7 51.2 28.8 42.6 25.9 46.5 18.4
Cancer surgery No 63.4 18.5 0.589 55.7 28.2 0.348 52.4 26.7 0.753 49.7 17.7 0.190
Yes 62.3 21.4 58.1 26.6 51.6 27.4 52.0 17.8
Chemotherapy No 63.9 21.1 0.527 59.2 26.9 0.365 58.2 28.8 0.008 51.6 18.6 0.678
Yes 62.5 19.9 56.3 27.5 50.1 26.2 50.7 17.5
Radiation therapy No 65.3 19.2 0.005 57.6 27.1 0.645 55.1 26.3 0.006 52.4 17.4 0.054
Yes 59.9 21.0 56.3 27.8 48.0 27.3 49.1 18.1
Immunotherapy No 64.5 19.3 0.073 57.4 26.4 0.771 56.9 25.8 0.001* 51.4 17.3 0.615
Yes 61.1 20.9 56.6 28.4 47.9 27.2 50.6 18.3
Antibodies No 63.4 20.4 0.333 57.5 27.5 0.332 53.0 26.1 0.431 51.1 17.5 0.993
Yes 61.3 19.0 54.5 27.5 50.4 29.6 51.0 19.2
Metastasis No 64.9 20.2 0.001* 59.9 26.5 0.001* 56.3 26.2 0.001* 53.6 17.0 0.001*
Yes 58.1 19.4 50.3 28.2 42.1 26.3 44.8 17.9
Fever No 66.4 18.5 0.001* 59.7 26.4 0.010 57.1 26.2 0.001* 54.1 17.8 0.001*
Yes 57.4 21.4 52.8 28.4 44.1 26.4 46.1 16.6
Family support No 59.5 24.8 0.292 57.4 28.2 0.919 54.5 30.3 0.547 48.8 17.0 0.440
Yes 63.1 19.7 57.0 27.3 51.7 26.7 51.1 17.8
Chronic disease other than
cancer
No 63.3 19.8 0.508 57.5 27.0 0.609 54.3 27.0 0.018 52.9 17.6 0.003
Yes 62.0 20.8 56.1 28.0 48.1 26.8 47.7 17.6
Regular exercise No 60.8 20.7 0.003 53.7 27.4 0.001* 48.2 26.7 0.001* 48.4 17.9 0.001*
Yes 66.9 18.4 63.8 26.0 59.7 26.1 56.2 16.3




Of the 438 cancer patients studied, 64% were female and
28.4% had a family history of cancer. The average age of
the sample was 52.9 (±SD = 17.3) with a range of 14–97 years.
The median number of months after-cancer diagnoses was 12
(interquartile range 5–24 months). The majority of subjects
(76.8%) received chemotherapy, 41.3% had cancer stage III
or IV, 30.5% had metastasis, and 24.8% were treated with
antibiotics. Other patient characteristics are reported in
Table 1.
Bivariate Analyses
The mean scores by sociodemographics, clinical symptoms,
and cancer treatments of each of the eight QoL domains mea-
sured by the SF-36 are presented in Tables 1 and 2 and Fig. 1.
The mean physical function was 48.30 (±SD = 29.4).
According to subgroup analyses, the elderly, those lacking
formal education, the unemployed, those diagnosed with stage
III/IV, those with metastasis, and those with chronic disease
other than cancer have significantly worse physical functions
than the other cancer patients. However, regular exercise was
predictive of increasing physical function. Higher mean scores
of physical functions were found in patients with breast
cancer, followed by patients with leukemia, lymphoma, colo-
rectal, and other cancer types.
The mean scale score for role limitations due to physical
health was 25.9 (±SD = 37.2). A greater impact on role limi-
tations due to physical health was found in cancer patients
with fever. The mean scale score for role limitations due to
emotional problems was 31.6 (±SD = 41.4). Cancer patients
with stage III or IV, multiple tumors, and fever reported sig-
nificantly poorer role limitations due to emotional problems
when compared to their counterparts. The mean scale score
for vitality was 43.9 (±SD = 22.0), and significantly lower
scores on vitality were observed in patients with old age, stage
III or IV, multiple tumors, metastasis, and fever when com-
pared to their counterparts. However, patients who regularly
exercised reported higher scores on vitality than those who did
not exercise.
The mean scale score for emotional wellbeing was 62.8
(±SD = 20.2). Lower mean scores on emotional wellbeing
was found in cancer patients with metastasis and fever when
compared to their counterparts. The mean scale score for so-
cial functioning was 57.0 (±SD = 27.4). Cancer patients with
stage III or IV and metastasis reported significantly lower
scores on social functioning when compared to their counter-
parts, while patients who practiced regular exercise reported
higher scores on social functioning than those who did not.
The mean scale score for pain was 52.0 (±SD = 27.0). Bodily
pain was significantly increased in patients with a family
Fig. 1 Error bar chart: impact of cancer complications on bodily pain ratings. Notes: The higher the score, the less pain
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history of cancer, stage III or IV, multiple tumors, receiving
immunotherapy, metastasis, and fever, while patients who reg-
ularly exercised reported less bodily pain than those who did
not exercise. The mean scale score for general health was 50.9
(±SD = 17.8). Patients with stage III or IV, multiple tumors,
metastasis, and fever reported lower scores on general health
when compared to their counterparts.
Regression Analyses
Multivariate analyses (Table 3) showed that elderly and stage
III or IV were found to be significant negative predictors of
physical health (decrease in physical health scores of 13.79
and 7.82, respectively), while regular exercise was found to be
a significant positive predictor of physical health (increase in
physical health score of 8.82). A family history of cancer had a
negative impact on role limitations due to physical health (de-
crease in role limitations due to physical health score of 10.3).
Patients with chronic disease other than cancer had a positive
impact on role limitations due to emotional problems (increase
in role limitations due to emotional problem score of 19.66).
Poor vitality was predicted by the elderly and those receiving
radiation therapy (decrease in vitality scores of 8.11 and 5.92,
respectively), while the presence of other chronic diseases and
regular exercise were positive predictors of vitality (increase
in vitality scores of 5.11 and 5.54, respectively).
Family history of cancer, newly diagnosed cancer patients
(first-year-after-cancer diagnosis), radiation therapy, and fever
were negatively correlated with poor emotional wellbeing (de-
crease in emotional wellbeing scores of 7.54, 5.20, 8.05, and
5.54, respectively), while family support was positively cor-
related with better emotional wellbeing (increase in emotional
wellbeing score of 9.70). Newly diagnosed cancer patients
and stage III or IV were negatively correlated with poor social
functioning (decrease in social functioning scores of 7.34 and
9.32, respectively), while regular exercise was positively cor-
related with better social functioning (increase in social func-
tioning score of 6.66). Cancer stage III or IV and fever had
negative impacts on pain (decrease in pain score of 8.08 and
8.01, respectively). Newly diagnosed cancer patients, leuke-
mia patients, those with metastasis, and those with fever had
negative impacts on general health (decrease in pain score of
6.12, 10.2, 8.34, and 4.93, respectively), while those with
family support and regular exercise regimens had positive
impacts on general health (increase in general health scores
of 7.43 and 4.97, respectively).
Discussion
This survey addresses health outcomes in a sample of Saudi
Arabians with different types of cancer. There is a lack of
research addressing health-related quality of life in patients
with different cancers in Saudi Arabia. This study is of interest
to QoL researchers and providers caring for cancer patients. It
has identified several predictors that appear to be correlated
with QoL in cancer patients. One of our findings was that the
elderly reported poorer vitality and physical function. These
findings are consistent with previous studies in demonstrating
older cancer patients may have a negative impact on QoL [5,
6]. It is also evident that patients with first-year-after-cancer
diagnosis reported a poorer health-related quality of life.
Specifically, patients with first-year-after-cancer diagnosis
tended to have poor emotional wellbeing, social function,
and general health (decrease in SF-36 scores of 5.20, 7.34,
and 6.12, respectively). An Iranian study has also shown that
first-year-after-cancer diagnosis is a predictor for poor physi-
cal, emotional, and social functioning [24]. Cancer disclosure
and patient’s quality of life and its impact on cancer treatment
and management must be assessed as their relation has yet to
be fully studied in Saudi Arabia.
Our study investigated the association between cancer treat-
ments and QoL. Vitality and emotional wellbeing are reported
significantly worse among those who received radiation thera-
py. Several other studies have also shown that poor QoL is
linked with cancer treatments [2–4]. An interventional study
is warranted to assess the impact of radiation therapy on QoL.
The study also compares the QoL of survivors with differ-
ent types of cancer. The QoL depends on the location of the
cancer. Leukemia was found to be associated with poor qual-
ity of life. This has been frequently addressed in various stud-
ies [25–27]. QoL assessment in patients with leukemia can
provide insights into the effects of leukemia treatment and
its management.
This study also investigated the association between regu-
lar exercise and QoL of patients with cancers. Other studies
have shown similar findings [28–30]. In our study, exercise
tended to improve physical function, role limitations due to
emotional problems, vitality, social function, and general
health (increase in SF-36 scores of 8.82, 9.75, 5.54, 6.66,
and 4.97, respectively). The effectiveness of physical exercise
must be assessed in Saudi cancer patients as an intervention to
improve QoL and control cancer outcomes. Several limita-
tions were noted. The cross-sectional design may not allow
causality assessment. There is a potential for sampling selec-
tion bias, in that cancer patients who are attending outpatient
clinics may more often be likely to participate, given the per-
ceived severity of their cancer. However, this research has
clearly identified several factors that appear to affect QoL in
cancer patients.
Conclusions
Regular exercise in cancer patients was a significant positive


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Newly diagnosed cancer patients (first-year-after-cancer diag-
nosis) tended to experience significantly poor QoL in several
domains. The effectiveness of exercise must be assessed in
Saudi cancer patients as an intervention to improve QoL.
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